Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

INSANE: Teva pharmaceuticals | Vintage Vibes

Nine More Drugmakers Join the Medicaid Pricing Deals, and the Effect on Your Pharmacy Bill Is Limited

Nine more drugmakers signed most-favored-nation Medicaid pricing deals, bringing the total to 26. Here is what changes and what does not.

Medical Daily

Trump Has Now Struck Drug Pricing Deals With 26 Companies. They Cover Nearly 90% Of The Branded Drug Market.

Nine midsize drugmakers joined the White House program and pledged at least $19.6 billion in U.S. manufacturing investments.

International Business Times

Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump says

Nine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of companies to twenty-six manufacturers. The deals cover medicines for chronic and rare diseases, benefiting Medicaid programs. Sun Pharma will contribute antibiotics to the US Strategic Active Pharmaceutical Ingredients Reserve. These…

The Economic Times

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA recall of blood pressure pills due to cancer-causing contaminant may point to higher safety risks in older generic drugs

A generic blood pressure drug called prazosin, made by Teva Pharmaceuticals, is being recalled by the Food and Drug Administration because it contains elevated levels of cancer-causing chemicals called nitrosamines.

The Conversation

Blood Pressure Medication Recalled Because Of Cancer Risk: What Is Prazosin Hydrochloride

Teva Pharmaceuticals orders a nationwide recall of their Prazosin Hydrochloride capsules.

International Business Times UK

Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now

Teva Pharmaceuticals is the world's largest generic drug maker with over 500 generics in its portfolio, but shares sold off on its recent earnings, buying opp?

MarketBeat

2 Generic Drug Stocks Ready to Surge in 2025

Explore how Teva Pharmaceuticals and Viatris are leading the generics industry with strong growth, robust pipelines, and strategies for 2025 success.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

New Generic Diabetes Drug Shows How Medical Innovation Works

The drugmaker Teva Pharmaceuticals made history in June by launching the first-ever generic version of a GLP-1 diabetes drug.

International Business Times

Teva Pharmaceuticals Stock Has Unusual Call Options Activity After Its Q1 Results

Teva Pharmaceuticals, the generic drug maker, posted good Q1 results today, reaffirming its forecast for significant free cash flow in 2024. That led to unusual call options activity based on a Barchart report.

Barchart

Teva to pay $225M to settle cholesterol drug price-fixing charges

The generic drug maker Teva Pharmaceuticals agreed Monday to pay $225 million to settle price-fixing charges related to sales of a widely used cholesterol-lowering drug

The Independent UK

The process of cartelisation

How entry of competitors affect a cartel

The Hindu

People

Donald Trump

212,712 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.